Boston Heart Diagnostics Corp. v. GeneAlign, LLC (17-cv-11412).

  • October 10, 2018

Judge Talwani found GeneAlign in default after it failed to respond to Boston Heart Diagnostic 2019s patent infringement complaint and entered an injunction barring GeneAlign from making, using, selling or offering for sale any SLCO1B1 test. She further awarded BHD costs and fees totaling $15,641.49 after determining, taking the allegations of the complaint as true, that the case was exceptional under 35 U.S.C. 00a7 285.

By submitting this form, you are consenting to receive marketing emails from: Lando & Anastasi, LLP. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

SHARE THIS POST

How can we help you?

Get in Touch